Dr. Ryan Saadi, M.D., M.P.H., is currently the Global Vice President of Evidence, Market Access, & Pricing Department at CSL Behring. He has spent the past 25 years in leadership positions in hospital administration, managed care, and in the pharmaceutical, biotechnology, and medical device industries.
Dr. Saadi has a strong commitment to improving health outcomes and addressing the opportunities and challenges associated with patient access. Access to new medical technologies is becoming increasingly complex given the shift towards cost and value, the introduction of diverse value assessment metrics, and healthcare models. Dr. Saadi has an acute appreciation of how the U.S. and global health care systems will be shaped by these changes.
Within this changing environment, Dr. Saadi’s proactive and collaborative approach has ensured patient access to innovative technologies in almost all therapeutic areas, including therapies for rare diseases. His vision for how the industry should adapt to this evidence-based, value-focused market is articulated in his book, “The Science of Commerce”.
Dr. Saadi is also currently a voting member of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC), which provides technical advice to assist the Centers for Medicare & Medicaid Services (CMS) in determining reasonable and necessary uses of medical services and technologies.
Dr. Saadi is a graduate of Yale School of Medicine and Dhaka Medical College. He is also an alumnus of the Harvard Business School Executive Education. He is a frequent keynote speaker and contributor to various global policy forums and scientific journals and was recognized as one of PharmaVoice magazine’s 100 most Inspiring Leaders in the life sciences industry in 2011 and 2015.